Intrathecal Pumps Market Size To Reach $513.3 Million By 2030

Intrathecal Pumps Market Growth & Trends

The global intrathecal pumps market size is expected to reach at USD 513.3 million in 2030 and is projected to grow at a CAGR of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for advanced intrathecal pumps for rapid delivery of medications into the spinal cord for faster pain relief is expected to boost the industry's growth during the forecast period.The advantages associated with intrathecal pumps are anticipated to augment the industry growth. Medications, such as opioids, when given through an intrathecal pain pump give superior pain relief as well as reduce side effects. Also, a small amount of medication is required in pain pumps as compared to the amount of medication taken in pill form, thereby increasing its preference among individuals.

The drug delivery therapy systems offer numerous benefits, such as effective pain relief, high patient satisfaction, reduced side effects compared to oral medication, and reduced use of pain medication. In addition, this treatment is effective and safe when used as directed and can be customized by varying the dosage as per need. Hence, rising demand for targeted drug delivery systems is expected to boost industry growth.The complications associated with the intrathecal catheter are creating hindrance in the industry growth. Occlusion, lacerations, and disconnection of the catheter cause a sudden cessation of intrathecal drug administration due to intrathecal catheter failure. Also, the majority of drug delivery device-related adverse events occurdue to the failure of the intrathecal catheter.

 Request a free sample copy or view report summary: Intrathecal Pumps Market Report

Intrathecal Pumps Market Report Highlights

• The morphine type segment held the largest revenue share in 2023 as intrathecal morphine receives analgesic effect at a lower dose with less systematic side effects as compared to large dose oral opioids.

• The pain application segment is expected to grow at the fastest CAGR during the forecast period

• This is owing to the development of advanced intrathecal pumps having enhanced efficiency in treating pain-related disorders

• North America accounted for the largest revenue share in 2023 and is projected to maintain its dominant position throughout the forecast years

• This is attributed to the high prevalence of chronic back pain and increased R&D expenditure in countries, such as the U.S. and Canada

Intrathecal Pumps Market Segmentation

Grand View Research has segmented the global intrathecal pumps market report on the basis of type, application, and region:

Intrathecal Pumps Type Outlook (Revenue, USD Million, 2018 - 2030)

• Baclofen

• Bupivacaine

• Clonidine

• Morphine

• Ziconotide

• Others

Intrathecal Pumps Application Outlook (Revenue, USD Million, 2018 - 2030)

• Spasticity

• Pain

Intrathecal Pumps Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Intrathecal Pumps Market

• Medtronic plc

• Codman & Shurtleff

• Medallion Therapeutics

• Arrow International Inc.

• Tricumed GmbH;

• Codman & Shurtleff;

• Smith’s Medical;

• Teleflex Incorporated